Qld: Cancer patients to help vaccine research
Queenslanders suffering prostate, kidney or testicular cancer will be asked to helpdevelop a vaccine for the cancers by donating tumour tissue.
Researchers from the Queensland University of Technology and the Princess AlexandraHospital have signed an $800,000 research deal with UK-based biotech company ONYVAX.
The study will focus on urological tumours with the aim of developing a vaccine.
Queensland University of Technology Associate Professor JUDITH CLEMENTS says patientswith urological cancers will be asked by their doctors to donate cells from tumour biopsiesto the research.
She says tumour cells will be grown in the lab from the patients' tissue to betterunderstand how they work.
Tumour cells will be examined by ONYVAX for characteristics that may make the tumoursvulnerable to vaccine therapies.
AAP RTV jfs/ldj
KEYWORD: UROLOGICAL (BRISBANE)
Комментариев нет:
Отправить комментарий